b lakshminarayana's most recent trade in Natco Pharma Ltd. was a Disposal of 2,000 Equity Shares done at an average price of Rs. 1391.6 . Disclosure was reported to the exchange on Dec. 31, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for b lakshminarayana in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | Lakshminarayana Bolisetty | Director | Disposal | 31 Dec 2024 | 2,000 | 0 (0%) | 0.00% | 1391.6 | 2,783,220 | 30 Dec 2024 30 Dec 2024 |
Insider Trading | Equity Shares | Market Sale |
| Divi's Laboratories | B. Lakshminarayana | Designated Person | Disposal | 07 Jun 2021 | 1,500 | 24,100 (0.01%) | 0.00% | 4183.8 | 6,275,751 | 01 Jun 2021 01 Jun 2021 |
Insider Trading | Equity Shares | Market Sale |